Vanguard Group »

Prime Medicine shares owned by Vanguard Group

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $36M 4.1M 8.86
2023-09-30 $38M 4.0M 9.54
2023-06-30 $49M 3.3M 14.65
2023-03-31 $11M 884k 12.30
2022-12-31 $16M 873k 18.58